Abstract
Heart failure (HF) is a national and global epidemic affecting millions of patients worldwide. HF is characterized by intense remodeling of the myocardium and important metabolic changes in cardiomyocyte biology. These changes are thought to be both a cause and consequence of the remodeling process and, thus, important targets for new pharmacological therapies. It is thus critically impor…